Advisor Group Holdings, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Advisor Group Holdings, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.28 - $1.16 $69,161 - $286,524	-247,004 Reduced 39.33%	380,962 $125,000
Q1 2024 May 10, 2024	BUY	$1.06 - $1.67 $13,990 - $22,042	13,199 Added 2.15%	627,966 $728,000
Q4 2023 Feb 12, 2024	BUY	$1.26 - $1.79 $298,260 - $423,719	236,715 Added 62.61%	614,767 $1.04 Million
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $127,418 - $201,020	79,142 Added 26.48%	378,052 $684,000
Q2 2023 Aug 10, 2023	BUY	$1.14 - $1.95 $14,403 - $24,638	12,635 Added 4.41%	298,910 $555,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.19 $129,710 - $236,721	108,092 Added 60.66%	286,275 $380,000
Q4 2022 Feb 10, 2023	BUY	$1.63 - $3.52 $145,086 - $313,315	89,010 Added 99.82%	178,183 $301,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $5,837 - $29,908	7,997 Added 9.85%	89,173 $278,000
Q2 2022 Aug 10, 2022	BUY	$2.2 - $4.2 $61,325 - $117,075	27,875 Added 52.3%	81,176 $194,000
Q1 2022 May 04, 2022	BUY	$2.83 - $8.69 $25,993 - $79,817	9,185 Added 20.82%	53,301 $215,000
Q3 2021 Nov 05, 2021	BUY	$9.15 - $13.28 $403,661 - $585,860	44,116 New	44,116 $510,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.